Hemoptysis is a common clinical manifestation in patients with bronchiectasis and one of the main causes for hospitalization, and massive hemoptysis is the most dangerous clinical manifestation in patients with bronchiectasis with high mortality. The pathogenesis of hemoptysis due to bronchiectasis is that long-term chronic inflammation and hypoxia induce bronchiectasis and stimulate bronchial angiogenesis, and finally rupture to lead to different degrees of hemoptysis. At present, there is no unified standard for the definition of massive hemoptysis due to bronchiectasis. Medical history and physical examination, laboratory tests and impact studies contribute to the diagnosis of massive hemoptysis due to bronchiectasis and to the determination of the bleeding point. Maintenance of airway balance and hemostasis are the focuses of treatment for massive hemoptysis due to upper bronchiectasis, among which hemostasis includes medical conservative treatment, bronchial artery embolization and surgical treatment.